Actively hiring
Molecular Diagnostics
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Ship2B
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…

Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…

Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…

RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…

Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting…

Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…

Ship2B 




